Evolent Health, Inc. EVH Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.89B+0.7% | $1.88B-8.7% | $2.05B-6.5% | $2.2B-8.5% | $2.4B-6.1% | ||
| $1.51B+2.1% | $1.48B-11.9% | $1.68B-8.8% | $1.84B-9.7% | $2.03B-7.1% | ||
| $381.19M-4.7% | $399.88M+5.7% | $378.34M+5.3% | $359.26M-1.8% | $365.72M-0.4% | ||
| 20.2%-1.1pp | 21.3%+2.9pp | 18.4%+2.1pp | 16.4%+1.1pp | 15.2%+0.9pp | ||
| $298.28M-1.8% | $303.87M+8.9% | $278.91M+3.9% | $268.38M+2.3% | $262.36M-0.3% | ||
| $2.31B+0.9% | $2.29B+10.2% | $2.07B-7.1% | $2.23B-8.0% | $2.43B-6.5% | ||
| -$419.12M-2.2% | -$410.14M-1,900% | -$20.5M+45.6% | -$37.66M-31.2% | -$28.7M+29.1% | ||
| -22.2%-0.3pp | -21.9%-20.9pp | -1%+0.7pp | -1.7%-0.5pp | -1.2%+0.4pp | ||
| $63.95M+11.3% | $57.47M+27.2% | $45.18M+30.1% | $34.72M+19.3% | $29.11M+17.7% | ||
| $1.04M+317% | $249K-34.1% | $378K+48.2% | $255K+37.8% | $185K-23.2% | ||
| -$497.21M+7.0% | -$534.64M-318% | -$127.75M+2.9% | -$131.55M-20.2% | -$109.47M-73.7% | ||
| -$686K-444% | -$126K-129% | $430K+139% | -$1.1M-116% | -$508K+64.0% | ||
| -$496.52M+7.1% | -$534.51M-317% | -$128.18M+1.7% | -$130.45M-19.7% | -$108.96M-76.8% | ||
| -26.3%+2.2pp | -28.5%-22.2pp | -6.2%-0.3pp | -5.9%-1.4pp | -4.5%-2.1pp | ||
| -$4.76+7.6% | -$5.15-226% | -$1.58+1.9% | -$1.61-30.9% | -$1.23-50.0% | ||
| -$305.77M-3.9% | -$294.29M-470% | $79.61M+16.1% | $68.54M-18.6% | $84.23M+8.1% | ||
| -16.2%-0.5pp | -15.7%-19.6pp | 3.9%+0.8pp | 3.1%-0.4pp | 3.5%+0.5pp | ||
| -$419.12M-2.2% | -$410.14M-1,900% | -$20.5M+45.6% | -$37.66M-31.2% | -$28.7M+29.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Evolent Health, Inc.'s revenue?
- Evolent Health, Inc. (EVH) generated $1.9B in revenue over the trailing twelve months, down 21.3% year over year.
- Is Evolent Health, Inc. profitable?
- Evolent Health, Inc. is not currently profitable: it reported a net loss of $496.5M over the trailing twelve months, a -26.3% net margin.
- What are Evolent Health, Inc.'s profit margins?
- Gross margin is 20.2% and operating margin is -22.2%, with a -26.3% net margin.
- What is Evolent Health, Inc.'s earnings per share?
- Evolent Health, Inc.'s diluted EPS over the trailing twelve months is $-4.76.
- Where does Evolent Health, Inc.'s income statement data come from?
- Every line is extracted from Evolent Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
